EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 S

Ensembl ID : ENSSVLG00005014029
Gene Symbol: CACNA1S
1 Cross references
259 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSSVLG00005000589
Gene Symbol: CNR2
1 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 1

Ensembl ID : ENSSVLG00005003719
Gene Symbol: CA1
1 Cross references
285 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSSVLG00005019375
Gene Symbol: CA12
1 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 14

Ensembl ID : ENSSVLG00005000883
Gene Symbol: CA14
1 Cross references
210 Possible Orthologues:

Carbonic Anhydrase 2

Ensembl ID : ENSSVLG00005003764
Gene Symbol: CA2
1 Cross references
282 Possible Orthologues:

Carbonic Anhydrase 3

Ensembl ID : ENSSVLG00005003745
Gene Symbol: CA3
1 Cross references
307 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSSVLG00005007650
Gene Symbol: CA4
1 Cross references
267 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSSVLG00005024653
Gene Symbol: CA5A
1 Cross references
167 Possible Orthologues:

Carbonic Anhydrase 5b

Ensembl ID : ENSSVLG00005018120
Gene Symbol: CA5B
1 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSSVLG00005004270
Gene Symbol: CA6
1 Cross references
218 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSSVLG00005025581
Gene Symbol: CA7
1 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).